Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Neoplasms of the CNS

  Free Subscription

Articles published in Br J Cancer

Retrieve available abstracts of 55 articles:
HTML format

Single Articles

    February 2024
  1. CHIANG JY, Wei ST, Chang HJ, Chen DC, et al
    ABCC4 suppresses glioblastoma progression and recurrence by restraining cGMP-PKG signalling.
    Br J Cancer. 2024 Feb 12. doi: 10.1038/s41416-024-02581.
    PubMed     Abstract available

  2. PRETE AA, Angerilli V, Bergamo F, Vettore V, et al
    HER2 expression and genOmic characterization of rESected brain metastases from colorectal cancer: the HEROES study.
    Br J Cancer. 2024 Feb 12. doi: 10.1038/s41416-023-02569.
    PubMed     Abstract available

  3. MOGENSEN H, Tettamanti G, Frederiksen LE, Talback M, et al
    Educational attainment in survivors of childhood cancer in Denmark, Finland, and Sweden.
    Br J Cancer. 2024;130:260-268.
    PubMed     Abstract available

  4. FLECCHIA C, Auclin E, Alouani E, Mercier M, et al
    Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study.
    Br J Cancer. 2024;130:442-449.
    PubMed     Abstract available

    January 2024
  5. HEYMER EJ, Hawkins MM, Winter DL, Teepen JC, et al
    Risk of subsequent gliomas and meningiomas among 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study.
    Br J Cancer. 2024 Jan 19. doi: 10.1038/s41416-024-02577.
    PubMed     Abstract available

  6. HALLAL SM, Tuzesi A, Sida LA, Xian E, et al
    Glioblastoma biomarkers in urinary extracellular vesicles reveal the potential for a 'liquid gold' biopsy.
    Br J Cancer. 2024 Jan 11. doi: 10.1038/s41416-023-02548.
    PubMed     Abstract available

    November 2023
  7. TRIVEDI R, Bhat KP
    Liquid biopsy: creating opportunities in brain space.
    Br J Cancer. 2023;129:1727-1746.
    PubMed     Abstract available

    October 2023
  8. THOMAS EM, Wright JA, Blake SJ, Page AJ, et al
    Advancing translational research for colorectal immuno-oncology.
    Br J Cancer. 2023;129:1442-1450.
    PubMed     Abstract available

    September 2023
  9. VANDERLINDEN A, Jones CG, Myers KN, Rominiyi O, et al
    DNA damage response inhibitors enhance tumour treating fields (TTFields) potency in glioma stem-like cells.
    Br J Cancer. 2023 Sep 30. doi: 10.1038/s41416-023-02454.
    PubMed     Abstract available

  10. CHENG S, McLaughlin JR, Brown MC, Al-Sawaihey H, et al
    Correction: Maternal and childhood medical history and the risk of childhood brain tumours: a case-control study in Ontario, Canada.
    Br J Cancer. 2023 Sep 13. doi: 10.1038/s41416-023-02415.

  11. HVIDTFELDT UA, Chen J, Rodopoulou S, Strak M, et al
    Long-term air pollution exposure and malignant intracranial tumours of the central nervous system: a pooled analysis of six European cohorts.
    Br J Cancer. 2023;129:656-664.
    PubMed     Abstract available

    August 2023
  12. NTAFOULIS I, Kleijn A, Ju J, Jimenez-Cowell K, et al
    Ex vivo drug sensitivity screening predicts response to temozolomide in glioblastoma patients and identifies candidate biomarkers.
    Br J Cancer. 2023 Aug 24. doi: 10.1038/s41416-023-02402.
    PubMed     Abstract available

  13. ZHAN Y, Song Y, Qiao W, Sun L, et al
    Focused ultrasound combined with miR-1208-equipped exosomes inhibits malignant progression of glioma.
    Br J Cancer. 2023 Aug 14. doi: 10.1038/s41416-023-02393.
    PubMed     Abstract available

  14. PARK J, Shim JK, Lee M, Kim D, et al
    Classification of IDH wild-type glioblastoma tumorspheres into low- and high-invasion groups based on their transcriptional program.
    Br J Cancer. 2023 Aug 9. doi: 10.1038/s41416-023-02391.
    PubMed     Abstract available

    July 2023
  15. LOPEZ J, Lai-Kwon J, Molife R, Welsh L, et al
    A Phase 1/2A trial of idroxioleic acid: first-in-class sphingolipid regulator and glioma cell autophagy inducer with antitumor activity in refractory glioma.
    Br J Cancer. 2023 Jul 24. doi: 10.1038/s41416-023-02356.
    PubMed     Abstract available

    June 2023
  16. ZHANG G, Zhu Q, Fu G, Hou J, et al
    Correction to: TRIP13 promotes the cell proliferation, migration and invasion of glioblastoma through the FBXW7/c-MYC axis.
    Br J Cancer. 2023 Jun 19. doi: 10.1038/s41416-023-02305.

    May 2023
  17. CHENG S, McLaughlin JR, Brown MC, Al-Sawaihey H, et al
    Maternal and childhood medical history and the risk of childhood brain tumours: a case-control study in Ontario, Canada.
    Br J Cancer. 2023 May 10. doi: 10.1038/s41416-023-02281.
    PubMed     Abstract available

  18. CROMIE KJ, Hughes NF, Milner S, Crump P, et al
    Socio-economic and ethnic disparities in childhood cancer survival, Yorkshire, UK.
    Br J Cancer. 2023;128:1710-1722.
    PubMed     Abstract available

    April 2023
  19. LYU L, Jiang Y, Ma W, Li H, et al
    Single-cell sequencing of PIT1-positive pituitary adenoma highlights the pro-tumour microenvironment mediated by IFN-gamma-induced tumour-associated fibroblasts remodelling.
    Br J Cancer. 2023;128:1117-1133.
    PubMed     Abstract available

    March 2023
  20. KIANG KM, Tang W, Song Q, Liu J, et al
    Targeting unfolded protein response using albumin-encapsulated nanoparticles attenuates temozolomide resistance in glioblastoma.
    Br J Cancer. 2023 Mar 17. doi: 10.1038/s41416-023-02225.
    PubMed     Abstract available

    February 2023
  21. PASQUALETTI F, Zanotti S
    Nonrandomised controlled trial in recurrent glioblastoma patients: the promise of autologous tumour lysate-loaded dendritic cell vaccination.
    Br J Cancer. 2023 Feb 15. doi: 10.1038/s41416-023-02194.
    PubMed     Abstract available

  22. WALLACE ND, Dunne MT, McArdle O, Small C, et al
    Efficacy and toxicity of primary re-irradiation for malignant spinal cord compression based on radiobiological modelling: a phase II clinical trial.
    Br J Cancer. 2023;128:576-585.
    PubMed     Abstract available

    January 2023
  23. BOTTOSSO M, Griguolo G, Sinoquet L, Guarascio MC, et al
    Prognostic impact of extracranial disease control in HER2+ breast cancer-related brain metastases.
    Br J Cancer. 2023 Jan 30. doi: 10.1038/s41416-023-02153.
    PubMed     Abstract available

    October 2022
  24. PIBUEL MA, Poodts D, Molinari Y, Diaz M, et al
    The importance of RHAMM in the normal brain and gliomas: physiological and pathological roles.
    Br J Cancer. 2022 Oct 7. pii: 10.1038/s41416-022-01999.
    PubMed     Abstract available

    September 2022
  25. ZHANG G, Tan R, Wan S, Yang R, et al
    HECTD3 regulates the tumourigenesis of glioblastoma by polyubiquitinating PARP1 and activating EGFR signalling pathway.
    Br J Cancer. 2022 Sep 10. pii: 10.1038/s41416-022-01970.
    PubMed     Abstract available

  26. ABIKO K, Hamanishi J, Matsumura N, Mandai M, et al
    Dynamic host immunity and PD-L1/PD-1 blockade efficacy: developments after "IFN-gamma from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer".
    Br J Cancer. 2022 Sep 6. pii: 10.1038/s41416-022-01960.
    PubMed     Abstract available

    June 2022
  27. KOLSTEEG C, Hulleman E, Bianco J
    Emerging nanomedical strategies for direct targeting of pediatric and adult diffuse gliomas.
    Br J Cancer. 2022 Jun 17. pii: 10.1038/s41416-022-01884.
    PubMed     Abstract available

  28. CATANZARO D, Milani G, Bozza A, Bernardi M, et al
    Selective cell cycle arrest in glioblastoma cell lines by quantum molecular resonance alone or in combination with temozolomide.
    Br J Cancer. 2022 Jun 17. pii: 10.1038/s41416-022-01865.
    PubMed     Abstract available

  29. HABASHY KJ, Mansour R, Moussalem C, Sawaya R, et al
    Challenges in glioblastoma immunotherapy: mechanisms of resistance and therapeutic approaches to overcome them.
    Br J Cancer. 2022 Jun 4. pii: 10.1038/s41416-022-01864.
    PubMed     Abstract available

  30. GINER-CALABUIG M, De Leon S, Wang J, Fehlmann TD, et al
    Mutational signature profiling classifies subtypes of clinically different mismatch-repair-deficient tumours with a differential immunogenic response potential.
    Br J Cancer. 2022;126:1595-1603.
    PubMed     Abstract available

    April 2022
  31. YANG H, Yuan L, Ibaragi S, Li S, et al
    Angiogenin and plexin-B2 axis promotes glioblastoma progression by enhancing invasion, vascular association, proliferation and survival.
    Br J Cancer. 2022 Apr 13. pii: 10.1038/s41416-022-01814.
    PubMed     Abstract available

  32. ZHAN S, Lu L, Pan SS, Wei XQ, et al
    Targeting NQO1/GPX4-mediated ferroptosis by plumbagin suppresses in vitro and in vivo glioma growth.
    Br J Cancer. 2022 Apr 8. pii: 10.1038/s41416-022-01800.
    PubMed     Abstract available

    February 2022
  33. WEI S, Liu W, Xu M, Qin H, et al
    Cathepsin F and Fibulin-1 as novel diagnostic biomarkers for brain metastasis of non-small cell lung cancer.
    Br J Cancer. 2022 Feb 25. pii: 10.1038/s41416-022-01744.
    PubMed     Abstract available

  34. STARZER AM, Steindl A, Mair MJ, Deischinger C, et al
    Correction: Systemic inflammation scores correlate with survival prognosis in patients with newly diagnosed brain metastases.
    Br J Cancer. 2022 Feb 10. pii: 10.1038/s41416-022-01722.

  35. MAIR R, Mouliere F
    Cell-free DNA technologies for the analysis of brain cancer.
    Br J Cancer. 2022;126:371-378.
    PubMed     Abstract available

    December 2021
  36. HAN S, Meng L, Jiang Y, Cheng W, et al
    Correction: Lithium enhances the antitumour effect of temozolomide against TP53 wild-type glioblastoma cells via NFAT1/FasL signaling.
    Br J Cancer. 2021 Dec 22. pii: 10.1038/s41416-021-01551.

    November 2021
  37. MI E, Mauricaite R, Pakzad-Shahabi L, Chen J, et al
    Deep learning-based quantification of temporalis muscle has prognostic value in patients with glioblastoma.
    Br J Cancer. 2021 Nov 30. pii: 10.1038/s41416-021-01590.
    PubMed     Abstract available

    August 2021
  38. ENGEL AL, Lorenz NI, Klann K, Munch C, et al
    Correction: Serine-dependent redox homeostasis regulates glioblastoma cell survival.
    Br J Cancer. 2021 Aug 6. pii: 10.1038/s41416-021-01517.

  39. WIDODO SS, Dinevska M, Furst LM, Stylli SS, et al
    IL-10 in glioma.
    Br J Cancer. 2021 Aug 4. pii: 10.1038/s41416-021-01515.
    PubMed     Abstract available

    July 2021
  40. WANG Y, Ye F, Liang Y, Yang Q, et al
    Breast cancer brain metastasis: insight into molecular mechanisms and therapeutic strategies.
    Br J Cancer. 2021 Jul 5. pii: 10.1038/s41416-021-01424.
    PubMed     Abstract available

    June 2021
  41. ROMINIYI O, Vanderlinden A, Clenton SJ, Bridgewater C, et al
    Correction: Tumour treating fields therapy for glioblastoma: current advances and future directions.
    Br J Cancer. 2021 Jun 10. pii: 10.1038/s41416-021-01451.

    May 2021
  42. WU F, Liu YW, Li GZ, Zhai Y, et al
    Metabolic expression profiling stratifies diffuse lower-grade glioma into three distinct tumour subtypes.
    Br J Cancer. 2021 May 18. pii: 10.1038/s41416-021-01418.
    PubMed     Abstract available

  43. SINGH G, Manjila S, Sakla N, True A, et al
    Radiomics and radiogenomics in gliomas: a contemporary update.
    Br J Cancer. 2021 May 6. pii: 10.1038/s41416-021-01387.
    PubMed     Abstract available

    April 2021
  44. ZADEH SHIRAZI A, McDonnell MD, Fornaciari E, Bagherian NS, et al
    A deep convolutional neural network for segmentation of whole-slide pathology images identifies novel tumour cell-perivascular niche interactions that are associated with poor survival in glioblastoma.
    Br J Cancer. 2021 Apr 29. pii: 10.1038/s41416-021-01394.
    PubMed     Abstract available

    March 2021
  45. LASORELLA A, Iavarone A
    The making of the glioblastoma classification.
    Br J Cancer. 2021 Mar 25. pii: 10.1038/s41416-021-01360.
    PubMed     Abstract available

  46. WANG C, Haas MA, Yeo SK, Paul R, et al
    Autophagy mediated lipid catabolism facilitates glioma progression to overcome bioenergetic crisis.
    Br J Cancer. 2021 Mar 15. pii: 10.1038/s41416-021-01294.
    PubMed     Abstract available

    February 2021
  47. DOHERTY GJ, de Paula BHR
    Cannabinoids in glioblastoma multiforme-hype or hope?
    Br J Cancer. 2021 Feb 24. pii: 10.1038/s41416-021-01265.
    PubMed     Abstract available

  48. TWELVES C, Sabel M, Checketts D, Miller S, et al
    A phase 1b randomised, placebo-controlled trial of nabiximols cannabinoid oromucosal spray with temozolomide in patients with recurrent glioblastoma.
    Br J Cancer. 2021 Feb 24. pii: 10.1038/s41416-021-01259.
    PubMed     Abstract available

    January 2021
  49. STARZER AM, Steindl A, Mair MJ, Deischinger C, et al
    Systemic inflammation scores correlate with survival prognosis in patients with newly diagnosed brain metastases.
    Br J Cancer. 2021 Jan 21. pii: 10.1038/s41416-020-01254.
    PubMed     Abstract available

    November 2020
  50. BAILLEUX C, Eberst L, Bachelot T
    Treatment strategies for breast cancer brain metastases.
    Br J Cancer. 2020 Nov 30. pii: 10.1038/s41416-020-01175.
    PubMed     Abstract available

  51. ROMINIYI O, Vanderlinden A, Clenton SJ, Bridgewater C, et al
    Tumour treating fields therapy for glioblastoma: current advances and future directions.
    Br J Cancer. 2020 Nov 4. pii: 10.1038/s41416-020-01136.
    PubMed     Abstract available

    October 2020
  52. RABBIE R, Ferguson P, Wong K, Couturier DL, et al
    The mutational landscape of melanoma brain metastases presenting as the first visceral site of recurrence.
    Br J Cancer. 2020 Oct 7. pii: 10.1038/s41416-020-01090.
    PubMed     Abstract available

  53. SAUNDERS CN, Cornish AJ, Kinnersley B, Law PJ, et al
    Searching for causal relationships of glioma: a phenome-wide Mendelian randomisation study.
    Br J Cancer. 2020 Oct 6. pii: 10.1038/s41416-020-01083.
    PubMed     Abstract available

    August 2020
  54. BASHOUR SI, Ibrahim NK, Schomer DF, Hess KR, et al
    Central nervous system miliary metastasis in breast cancer: a case series analysis and proposed identification criteria of a rare metastasis subtype.
    Br J Cancer. 2020 Aug 4. pii: 10.1038/s41416-020-1008.
    PubMed     Abstract available

    April 2020
  55. THIRION PG, Dunne MT, Kelly PJ, Flavin A, et al
    Non-inferiority randomised phase 3 trial comparing two radiation schedules (single vs. five fractions) in malignant spinal cord compression.
    Br J Cancer. 2020;122:1315-1323.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge.